Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma

LJ Estcourt, CS Cohn, MB Pagano… - Annals of internal …, 2022 - acpjournals.org
Description: Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a
potential treatment of COVID-19. However, meta-analysis data and recommendations are …
被引用次数：64 相关文章
[HTML] nih.gov

[HTML][HTML] Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma

LJ Estcourt, CS Cohn, MB Pagano, C Iannizzi… - Annals of Internal … - ncbi.nlm.nih.gov
Methods: These guidelines are based on 2 living systematic reviews of randomized
controlled trials (RCTs) evaluating CCP from 1 January 2019 to 26 January 2022. There …

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma

LJ Estcourt, CS Cohn, MB Pagano… - Annals of internal …, 2022 - pure.johnshopkins.edu
Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a potential
treatment of COVID-19. However, meta-analysis data and recommendations are limited. The …

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma

LJ Estcourt, CS Cohn, MB Pagano… - Annals of internal …, 2022 - experts.umn.edu
Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a potential
treatment of COVID-19. However, meta-analysis data and recommendations are limited. The …

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma.

LJ Estcourt, CS Cohn, MB Pagano… - Annals of Internal …, 2022 - europepmc.org
Methods These guidelines are based on 2 living systematic reviews of randomized
controlled trials (RCTs) evaluating CCP from 1 January 2019 to 26 January 2022. There …

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma

LJ Estcourt, CS Cohn, MB Pagano, C Iannizzi… - 2022 - digitalrepository.unm.edu
Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a potential
treatment of COVID-19. However, meta-analysis data and recommendations are limited. The …

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma.

LJ Estcourt, CS Cohn, MB Pagano… - Annals of internal …, 2022 - escholarship.org
DescriptionCoronavirus disease 2019 convalescent plasma (CCP) has emerged as a
potential treatment of COVID-19. However, meta-analysis data and recommendations are …

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma

LJ Estcourt, CS Cohn, MB Pagano… - Annals of internal …, 2022 - profiles.wustl.edu
Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a potential
treatment of COVID-19. However, meta-analysis data and recommendations are limited. The …

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma

L Estcourt, C Cohn, M Pagano, C Iannizzi… - Annals of Internal …, 2022 - avesis.tedu.edu.tr
© 2022 American College of Physicians. All rights reserved. Description: Coronavirus
disease 2019 convalescent plasma (CCP) has emerged as a potential treatment of COVID …

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma

LJ Estcourt, CS Cohn, MB Pagano… - Annals of internal …, 2022 - pubmed.ncbi.nlm.nih.gov
Description Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a
potential treatment of COVID-19. However, meta-analysis data and recommendations are …